Nathalia Velasquez, MD
Otolaryngic Allergy · Fremont, CANPI 1477903987
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Aerin Medical Inc. at 58.0% of the total. Reporting peaked in 2023 at $2,355 and has fallen 93.7% since, to $149 in 2025.
Across 40 payments — averaging $89.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Olympus Corporation Of The Americas$570
- Stryker$324
- Johnson & Johnson$190
- Medtronic$181
- Optinose US, Inc.$127
- plus $107 from 3 others
What the payments were for
- Consulting fees$40011%
- Travel & lodging$1,47541%
- Food & beverage$1,69748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 21 | $2,074 |
| Olympus Corporation Of The Americas | 5 | $570 |
| Stryker | 3 | $324 |
| Johnson & Johnson | 1 | $190 |
| Medtronic | 5 | $181 |
| Optinose US, Inc. | 1 | $127 |
| Cook Medical LLC | 1 | $64 |
| Baxter Healthcare | 2 | $24 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,387
- PK Diego$522
- Celon System$522
- Olympus ENT Instruments$522
- NA$190
- CORE$154
- RHINAER STYLUS$140
- N/A$131
- Xhance$127
- PROPEL$106
How this compares
Too few otolaryngic allergy providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 142 | $5,799 |
| Azelastine Hcl | 77 | $2,597 |
| Mometasone Furoate | 15 | $1,532 |
| Fluticasone Propionate | 62 | $1,175 |
| Mupirocin | 46 | $389 |
| Famotidine | 15 | $358 |
| Omeprazole | 26 | $328 |
| Montelukast Sodium | 25 | $226 |
| Pantoprazole Sodium | 24 | $158 |
| Chlorhexidine Gluconate | 12 | $148 |
| Doxycycline Hyclate | 17 | $133 |
| Methylprednisolone | 16 | $121 |
| Prednisone | 23 | $89 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Fremont
- Naveen BhandarkarOrange$639K
- Akira IshiyamaLos Angeles$105K
- Edward KuanOrange$90K
- Mary DereberyLos Angeles$3K
- David LiuStanford$433
- Donald BurtMorgan Hill$417
- Ivor EmanuelSan Francisco$253
- Quoc NguyenGarden Grove$206
- Sidney FishmanNewport Beach$140
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.